Jonny Peter

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

Andrew Boulle, Mary‐Ann Davies, Hannah Hussey et al. · Clinical Infectious Diseases · 2020 · 593 citations · Full text

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

Grant Theron, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2013 · 437 citations

Point-of-care Xpert Mtb/rif, Pulmonary Tuberculosis, Primary Care +12

Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

Grant Theron, Jonny Peter, Richard N. van Zyl-Smit et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 308 citations

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

Jonny Peter, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2016 · 262 citations

Pulmonary Tuberculosis, Treatment And Prevention, Medicine +12

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?

Grant Theron, Jonny Peter, David W. Dowdy et al. · The Lancet Infectious Diseases · 2014 · 154 citations

Pulmonary Tuberculosis, Clinical Effectiveness, High Rates +9